Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,881 to 2,900 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| CCNG1 cyclin G1 | 900 HGNC:1592 | 1 | 56 | 0 | 0 | 1,201 | 2,141 |
| MAP1B microtubule associated protein 1B | 4131 HGNC:6836 | 1 | 30 | 0 | 0 | 1,454 | 2,141 |
| PCNT pericentrin | 5116 HGNC:16068 | 1 | 24 | 0 | 0 | 1,882 | 2,141 |
| PPIB peptidylprolyl isomerase B | 5479 HGNC:9255 | 1 | 101 | 0 | 0 | 1,634 | 2,141 |
| COL10A1 collagen type X alpha 1 chain | 1300 HGNC:2185 | 1 | 60 | 0 | 0 | 950 | 2,140 |
| MLN motilin | 4295 HGNC:7141 | 1 | 25 | 0 | 0 | 556 | 2,139 |
| RAB7A RAB7A, member RAS oncogene family | 7879 HGNC:9788 | 1 | 61 | 0 | 0 | 1,674 | 2,139 |
| ADARB1 adenosine deaminase RNA specific B1 | 104 HGNC:226 | 1 | 55 | 0 | 0 | 1,355 | 2,137 |
| EGLN3 egl-9 family hypoxia inducible factor 3 | 112399 HGNC:14661 | 1 | 78 | 4 | 113 | 1,232 | 2,134 |
| NRXN1 neurexin 1 | 9378 HGNC:8008 | 2 | 61 | 0 | 0 | 2,307 | 2,134 |
| DKC1 dyskerin pseudouridine synthase 1 | 1736 HGNC:2890 | 1 | 58 | 0 | 0 | 1,325 | 2,132 |
| SPHK2 sphingosine kinase 2 | 56848 HGNC:18859 | 1 | 47 | 1 | 11 | 1,129 | 2,132 |
| TMSB4X thymosin beta 4 X-linked | 7114 HGNC:11881 | 1 | 122 | 0 | 0 | 1,160 | 2,131 |
| GADD45B growth arrest and DNA damage inducible beta | 4616 HGNC:4096 | 1 | 44 | 0 | 0 | 1,506 | 2,130 |
| CACNA1S calcium voltage-gated channel subunit alpha1 S | 779 HGNC:1397 | 1 | 21 | 45 | 965 | 1,381 | 2,128 |
| HTRA2 HtrA serine peptidase 2 | 27429 HGNC:14348 | 1 | 56 | 0 | 0 | 1,159 | 2,128 |
| HLA-DMA major histocompatibility complex, class II, DM alpha | 3108 HGNC:4934 | 1 | 77 | 0 | 0 | 1,799 | 2,126 |
| LORICRIN loricrin cornified envelope precursor protein | 4014 HGNC:6663 | 1 | 19 | 0 | 0 | 868 | 2,126 |
| CCNA1 cyclin A1 | 8900 HGNC:1577 | 1 | 26 | 0 | 0 | 1,165 | 2,123 |
| MIR98 microRNA 98 | 407054 HGNC:31649 | 0 | 0 | 0 | 0 | 688 | 2,123 |
Code
curl "https://conductscience.org/api/genes/v1?page=145"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=145
{
"data": {
"total": 193990,
"results": [
{
"id": "900",
"title": "CCNG1: cyclin G1",
"summary": "NCBI Gene 900. 1 protein, 56 patents, 0 drugs, 0 trials, 1,201 NIH grants and 2,141 papers.",
"record": "/library/genes/900",
"gene_id": 900,
"symbol": "CCNG1",
"name": "cyclin G1",
"hgnc_id": "HGNC:1592",
"counts": {
"proteins": 1,
"patents": 56,
"drugs": 0,
"trials": 0,
"grants": 1201,
"papers": 2141
}
},
{
"id": "4131",
"title": "MAP1B: microtubule associated protein 1B",
"summary": "NCBI Gene 4131. 1 protein, 30 patents, 0 drugs, 0 trials, 1,454 NIH grants and 2,141 papers.",
"record": "/library/genes/4131",
"gene_id": 4131,
"symbol": "MAP1B",
"name": "microtubule associated protein 1B",
"hgnc_id": "HGNC:6836",
"counts": {
"proteins": 1,
"patents": 30,
"drugs": 0,
"trials": 0,
"grants": 1454,
"papers": 2141
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=146",
"request_id": "hXJKrkgWHxsSnxE6"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant